Novel immune strategies to enhance beta cell replacement therapies for type 1 diabetes (T1D)
BUDGET: USD 350,000 per year for a maximum of two years. - Expiry date: October 25, 2021
Juvenile Diabetes Research FoundationJDRF invites letters of intent for its novel strategies to enhance beta cell replacement therapies for type 1 diabetes (T1D) funding opportunity. This supports preclinical and clinical studies from academic or industry applicants with innovative and incremental immune...
